Five notes:
1. Researchers analyzed 1,001 venture capital investments in the PitchBook database across 227 spine surgery companies.
2. Investments were categorized into five groups: surgical devices, noninvasive devices, biotechnology, surgical software, and clinical services.
3. A total $5.3 billion was invested in spine surgery, and nonsurgical devices saw the lion’s share of 42.6%.
4. Surgical device investments made up 26.3% of that $5.3 billion, and biotechnology saw 22.2% of the share.
5. Annual investments increased by 1,782%, but there was a decline in 2023. That decline was “likely due to macroeconomic factors,” the study said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
